Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 4

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 4
---
 by any Selling Stockholders, except for funds to be received by the Company from the exercise of Investor Warrants by the Selling Stockholders, if and when such Investor Warrants are exercised for cash.

The Selling Stockholders, or their respective transferees, pledgees, donees or other successors-in-interest, may sell their Shares pursuant to this Prospectus at a fixed price of $1.0 per share until our Common Stock is quoted on the OTCQX or the OTCQB marketplace of OTC Market. or until the shares of our Common Stock are listed on a national securities exchange. At and after such time, the Selling Stockholders may sell all or a portion of their Shares through public or private transactions at prevailing market prices or at privately negotiated prices. The sale of the Shares by Selling Stockholders in the Resale Offering is not conditioned upon the successful completion of the sale of the Units by the Company in the Primary Offering.

On February 13, 2025, the last reported sale price
for our Common Stock on the OTC Market was $0.50 per share. The Selling Stockholders and any broker-dealers or agents that are involved
in selling the Shares may be deemed to be underwriters within the meaning of the Securities Act in connection with such sales. In such
event, any commissions received by such broker-dealers or agents and any profit on the resale of the Shares purchased by them may be deemed
to be underwriting commissions or discounts under the Securities Act.See“Determination of the Offering Price,” “Selling Stockholders”and “Plan of Distribution.”

The Selling Stockholders will pay all underwriting discounts and selling commissions relating to the sale of these shares. We have agreed to pay the legal, accounting, printing, and other expenses related to the registration of the sale of the Shares of Common Stock in this Offering. All of the net proceeds from the sale of the Shares in the Resale Offering by the Selling Stockholder will go to the Selling Stockholders. However, to the extent that the Investor Warrants held by the Selling Stockholders are exercised for cash, we will receive payment of the exercise price in connection with such exercise.

Investing in our securities involves a high degree of risk. You should invest in our securities only if you can afford to lose your entire investment. you should read and carefully consider risks described in the “ Risk Factors” section beginning on page 5 of this prospectus.

You should rely only on the information contained in this prospectus or any prospect